Breadcrumb

CTB News

RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response

Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...

Discovery of mechanics of drug targets for COVID-19

Scientists unravel inner workings of cell receptors involved in inflammatory diseases

RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children

Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available

RI-MUHC scientist part of McGill team delivering World Alzheimer Report 2021

Alzheimer’s Disease International webinar launches report on World Alzheimer Day, September 21

Research trainees are bridging the gap between science and the public

Two RI-MUHC research trainees share their experience as community outreach panelists

Promising development in the fight with cancer using artificial intelligence

New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...

New G protein inhibitor identified, with potential for cancer therapies

RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells

RI-MUHC success in grant competition for transplantation research

Researchers awarded funds from the Canadian Donation and Transplantation Research Program for...

RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer

Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...

Explore news and events at the RI-MUHC